901 related articles for article (PubMed ID: 26469693)
1. Diseases caused by mutations in ORAI1 and STIM1.
Lacruz RS; Feske S
Ann N Y Acad Sci; 2015 Nov; 1356(1):45-79. PubMed ID: 26469693
[TBL] [Abstract][Full Text] [Related]
2.
Silva-Rojas R; Laporte J; Böhm J
Front Physiol; 2020; 11():604941. PubMed ID: 33250786
[TBL] [Abstract][Full Text] [Related]
3. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
Nesin V; Wiley G; Kousi M; Ong EC; Lehmann T; Nicholl DJ; Suri M; Shahrizaila N; Katsanis N; Gaffney PM; Wierenga KJ; Tsiokas L
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4197-202. PubMed ID: 24591628
[TBL] [Abstract][Full Text] [Related]
4. CRAC channelopathies.
Feske S
Pflugers Arch; 2010 Jul; 460(2):417-35. PubMed ID: 20111871
[TBL] [Abstract][Full Text] [Related]
5. York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1.
Markello T; Chen D; Kwan JY; Horkayne-Szakaly I; Morrison A; Simakova O; Maric I; Lozier J; Cullinane AR; Kilo T; Meister L; Pakzad K; Bone W; Chainani S; Lee E; Links A; Boerkoel C; Fischer R; Toro C; White JG; Gahl WA; Gunay-Aygun M
Mol Genet Metab; 2015 Mar; 114(3):474-82. PubMed ID: 25577287
[TBL] [Abstract][Full Text] [Related]
6. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.
Feske S
Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822
[TBL] [Abstract][Full Text] [Related]
7. ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.
Bulla M; Gyimesi G; Kim JH; Bhardwaj R; Hediger MA; Frieden M; Demaurex N
J Physiol; 2019 Jan; 597(2):561-582. PubMed ID: 30382595
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficiency due to mutations in ORAI1 and STIM1.
Feske S; Picard C; Fischer A
Clin Immunol; 2010 May; 135(2):169-82. PubMed ID: 20189884
[TBL] [Abstract][Full Text] [Related]
9. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation.
Abdullaev IF; Bisaillon JM; Potier M; Gonzalez JC; Motiani RK; Trebak M
Circ Res; 2008 Nov; 103(11):1289-99. PubMed ID: 18845811
[TBL] [Abstract][Full Text] [Related]
10. A dominant STIM1 mutation causes Stormorken syndrome.
Misceo D; Holmgren A; Louch WE; Holme PA; Mizobuchi M; Morales RJ; De Paula AM; Stray-Pedersen A; Lyle R; Dalhus B; Christensen G; Stormorken H; Tjønnfjord GE; Frengen E
Hum Mutat; 2014 May; 35(5):556-64. PubMed ID: 24619930
[TBL] [Abstract][Full Text] [Related]
11. STIM1-Orai1 interactions and Orai1 conformational changes revealed by live-cell FRET microscopy.
Navarro-Borelly L; Somasundaram A; Yamashita M; Ren D; Miller RJ; Prakriya M
J Physiol; 2008 Nov; 586(22):5383-401. PubMed ID: 18832420
[TBL] [Abstract][Full Text] [Related]
12. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
[TBL] [Abstract][Full Text] [Related]
13. Role of STIM1/ORAI1-mediated store-operated Ca
Michelucci A; García-Castañeda M; Boncompagni S; Dirksen RT
Cell Calcium; 2018 Dec; 76():101-115. PubMed ID: 30414508
[TBL] [Abstract][Full Text] [Related]
14. Local Ca²+ entry via Orai1 regulates plasma membrane recruitment of TRPC1 and controls cytosolic Ca²+ signals required for specific cell functions.
Cheng KT; Liu X; Ong HL; Swaim W; Ambudkar IS
PLoS Biol; 2011 Mar; 9(3):e1001025. PubMed ID: 21408196
[TBL] [Abstract][Full Text] [Related]
15. The TAM-associated STIM1
Kim JH; Carreras-Sureda A; Didier M; Henry C; Frieden M; Demaurex N
Cell Calcium; 2022 Jul; 105():102615. PubMed ID: 35792400
[TBL] [Abstract][Full Text] [Related]
16. Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels.
Endo Y; Noguchi S; Hara Y; Hayashi YK; Motomura K; Miyatake S; Murakami N; Tanaka S; Yamashita S; Kizu R; Bamba M; Goto Y; Matsumoto N; Nonaka I; Nishino I
Hum Mol Genet; 2015 Feb; 24(3):637-48. PubMed ID: 25227914
[TBL] [Abstract][Full Text] [Related]
17. Defects in the STIM1 SOARα2 domain affect multiple steps in the CRAC channel activation cascade.
Höglinger C; Grabmayr H; Maltan L; Horvath F; Krobath H; Muik M; Tiffner A; Renger T; Romanin C; Fahrner M; Derler I
Cell Mol Life Sci; 2021 Oct; 78(19-20):6645-6667. PubMed ID: 34498097
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
